2020

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

COVID-19 risks turning back the clock on years of essential development work

Reflections on the World Health Assembly

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

In defence of WHO

HAI Follows Dutch Government Advice in Response to COVID-19

HAI Recognised for Commitment to Gender Equality

2019

A Momentous Week for Access to Medicines

Welcome to the new look website!

Dr Marg Ewen Receives the Helen Clark-JoPPP Award

2018

Staff Spotlight: Jaume Vidal

How WHO’s Internship Policy Became More Inclusive

A Week of Promise for Access to Medicines

What Role Can Civil Society Play in the European Regulatory Process?

Open Science for Health: Shaping the New Framework Programme

2017

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

Facing a Global Threat – Roadmap to Combat Antimicrobial Resistance and the Bumps Along the Way

The Forgotten Victims of Snakebite

Giving Snakebite Victims a Voice

Small country, big thinkers: Why it’s only natural for the Netherlands to take on a pioneering role in snakebite advocacy

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

2016

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69

Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event

2015

Can the WHO Set the Right Course for Antibiotics?

HAI urges MEPs to support key amendments to TTIP resolution

Successful week of advocacy for HAI delegation at 68th World Health Assembly